CN1185956A - A cancer medicine - Google Patents
A cancer medicine Download PDFInfo
- Publication number
- CN1185956A CN1185956A CN96114104A CN96114104A CN1185956A CN 1185956 A CN1185956 A CN 1185956A CN 96114104 A CN96114104 A CN 96114104A CN 96114104 A CN96114104 A CN 96114104A CN 1185956 A CN1185956 A CN 1185956A
- Authority
- CN
- China
- Prior art keywords
- gram
- cancer
- herba
- grams
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A medicine for curing lung cancer, breast cancer, uterus cancer, rectum cancer, cerebral tumor, esophagus cancer, stomach cancer and liver cancer is prepared from 15 Chinese-medicinal materials such as chicken gall, prepared Semen strychni powder, bilirubin, toad venom, ginseng, etc.
Description
The present invention is a kind of medicine for the treatment of cancer, and described medicine has excellent curative to multiple cancers such as pulmonary carcinoma, breast carcinoma, uterus carcinoma, rectal cancer, the cerebral tumor, esophageal carcinoma, gastric cancer, hepatocarcinoma.Belong to drug world.
Cancer is a great problem of current medical circle, and its PD is fast, and the mortality rate height directly threatens human healthy to a great extent.Because the pathogeny of cancer is unclear as yet, at present, generally take the method for Comprehensive Treatment in the world for tumor treatment.The medicine that is used for the treatment of tumor is a lot, but lacks especially effectively medicine.Especially all there is the broad-spectrum anti-cancer drug of therapeutic effect then very little especially for multiple cancer.
The object of the invention provides a kind of medicine for the treatment of cancer, and this medicine has excellent curative to multiple cancers such as pulmonary carcinoma, breast carcinoma, uterus carcinoma, rectal cancer, the cerebral tumor, esophageal carcinoma, gastric cancer, hepatocarcinoma.
Medicine of the present invention contains following pharmaceutical composition:
Chicken gall bladder 0.2-0.8 gram
Semen Strychni (processed) powder 0.010-0.030 gram
Bilirubin 0.005-0.050 gram
Venenum Bufonis 0.001-0.005 gram
Radix Ginseng 0.1-2 gram
Radix Codonopsis 0.5-5 gram
Rhizoma Atractylodis Macrocephalae 1-5 gram
Herba Agrimoniae 0.5-5 gram
Scolopendra 0.005-0.050 gram
Scorpio 0.005-0.050 gram
Herba Ephedrae 0.005-0.050 gram
Herba Cistanches 0.005-0.050 gram
Rhizoma Polygonati 0.005-0.050 gram
Olibanum 0.5-5 gram
Myrrha 0.5-5 gram
The optimum amount proportioning of each component is in the aforementioned pharmaceutical compositions:
Chicken gall bladder 0.5 gram
Semen Strychni (processed) powder 0.020 gram
Bilirubin 0.010 gram
Venenum Bufonis 0.001 gram
Radix Ginseng 1 gram
Radix Codonopsis 2 grams
The Rhizoma Atractylodis Macrocephalae 3 grams
Herba Agrimoniae 2 grams
Scolopendra 0.010 gram
Scorpio 0.010 gram
Herba Ephedrae 0.012 gram
Herba Cistanches 0.020 gram
Rhizoma Polygonati 0.020 gram
Olibanum 1 gram
Myrrha 1 gram
Aforementioned pharmaceutical compositions of the present invention can be prepared into common drug dosage form clinically according to the formulation method of routine, for example, and pill, tablet, powder, unguentum, oral liquid, capsule etc.All pharmaceutical preparatioies that contain pharmaceutical composition of the present invention and extract thereof all belong to protection scope of the present invention.
The preferred dosage form of the present invention is a watered pill.
The preparation method of watered pill is:
Form the each component mixing according to prescription, pulverize, cross 100 mesh sieves, add water, make the watered pill with pellet processing machine according to common process.
The advantage of medicine of the present invention is to have excellent curative for multiple cancer, can reach more than 90% to the pulmonary carcinoma cure rate, can reach 80% to the esophageal carcinoma cure rate, can reach more than 78% other cancer cure rate, this medicine has stronger analgesic effect to the pain of all kinds of cancerations.
Embodiment 1
Prescription:
Chicken gall bladder 0.5 gram
20 milligrams of Semen Strychni (processed) powders
10 milligrams of bilirubin
1 milligram of Venenum Bufonis
Radix Ginseng 1 gram
Radix Codonopsis 2 grams
The Rhizoma Atractylodis Macrocephalae 3 grams
Herba Agrimoniae 2 grams
10 milligrams of Scolopendras
10 milligrams of Scorpios
12 milligrams in Herba Ephedrae
20 milligrams of Herba Cistanches
20 milligrams of Rhizoma Polygonatis
Olibanum 1 gram
Myrrha 1 gram
Said medicine is mixed, be ground into medicated powder, it is an amount of to add water, makes the watered pill with comminutor.
Claims (2)
1, a kind of pharmaceutical composition for the treatment of cancer is characterized in that it contains:
Chicken gall bladder 0.2-0.8 gram
Semen Strychni (processed) powder 0.010-0.030 gram
Bilirubin 0.005-0.050 gram
Venenum Bufonis 0.001-0.005 gram
Radix Ginseng 0.1-2 gram
Radix Codonopsis 0.5-5 gram
Rhizoma Atractylodis Macrocephalae 1-5 gram
Herba Agrimoniae 0.5-5 gram
Scolopendra 0.005-0.050 gram
Scorpio 0.005-0.050 gram
Herba Ephedrae 0.005-0.050 gram
Herba Cistanches 0.005-0.050 gram
Rhizoma Polygonati 0.005-0.050 gram
Olibanum 0.5-5 gram
Myrrha 0.5-5 gram
2,, it is characterized in that it contains according to the said pharmaceutical composition of claim 1:
Chicken gall bladder 0.5 gram
Semen Strychni (processed) powder 0.020 gram
Bilirubin 0.010 gram
Venenum Bufonis 0.001 gram
Radix Ginseng 1 gram
Radix Codonopsis 2 grams
The Rhizoma Atractylodis Macrocephalae 3 grams
Herba Agrimoniae 2 grams
Scolopendra 0.010 gram
Scorpio 0.010 gram
Herba Ephedrae 0.012 gram
Herba Cistanches 0.020 gram
Rhizoma Polygonati 0.020 gram
Olibanum 1 gram
Myrrha 1 gram
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96114104A CN1185956A (en) | 1996-12-23 | 1996-12-23 | A cancer medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96114104A CN1185956A (en) | 1996-12-23 | 1996-12-23 | A cancer medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1185956A true CN1185956A (en) | 1998-07-01 |
Family
ID=5121923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96114104A Pending CN1185956A (en) | 1996-12-23 | 1996-12-23 | A cancer medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1185956A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084206C (en) * | 1999-05-20 | 2002-05-08 | 周金龙 | Cancer treating medicine and its preparation |
WO2002055075A3 (en) * | 2000-11-10 | 2003-12-31 | The President And Fellows Of Harvard College | Compounds and methods for regulating cell differentiation |
CN101143170B (en) * | 2006-09-12 | 2010-08-25 | 西安临潼少华中医乳腺肿瘤病研究所 | Traditional Chinese medicine composition for treating rectum cancer |
CN101675961B (en) * | 2008-09-18 | 2012-09-12 | 上海中医药大学附属曙光医院 | A medicinal preparation for treating breast cancer and preparation method thereof |
-
1996
- 1996-12-23 CN CN96114104A patent/CN1185956A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084206C (en) * | 1999-05-20 | 2002-05-08 | 周金龙 | Cancer treating medicine and its preparation |
WO2002055075A3 (en) * | 2000-11-10 | 2003-12-31 | The President And Fellows Of Harvard College | Compounds and methods for regulating cell differentiation |
CN101143170B (en) * | 2006-09-12 | 2010-08-25 | 西安临潼少华中医乳腺肿瘤病研究所 | Traditional Chinese medicine composition for treating rectum cancer |
CN101675961B (en) * | 2008-09-18 | 2012-09-12 | 上海中医药大学附属曙光医院 | A medicinal preparation for treating breast cancer and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1084206C (en) | Cancer treating medicine and its preparation | |
CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
CN1895619A (en) | Chinese-medicinal composition for preventing and treating liver disease and its preparation | |
CN1265911A (en) | Medicine for treating cardiovascular disease and preparation process thereof | |
CN1185956A (en) | A cancer medicine | |
CN1250264C (en) | Capsule for curing hyperplasia of mammary glands and its preparation method | |
CN1539458A (en) | Chinese materia medica preparation made from gen-seng and astragalus root for strengthening the body resistance and anti cancer as well as producing method | |
CN1709288A (en) | Medicinal composition, and its preparing method and use | |
CN1857684A (en) | Compound Chinese medicine preparation for removing toxic matter, dispersing blood clots and strengthing body's resistance and its preparaing process | |
CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
CN1233411C (en) | Natural medicine and its preparation of eliminating tumour internally | |
CN1332006A (en) | Leukoderma treating medicine | |
CN100346812C (en) | Medicine for treating hyperplasia of mammary glands and fibroadenoma of breast and prepn. technique | |
CN1059117C (en) | Katsutoxin pill for tumor and preparing method thereof | |
CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
CN1042495C (en) | Medicine for benefitting Qi, removing cancer and raising leucocyte and its prepn. | |
CN1207002C (en) | Antineoplastic composite and its prepn process and use | |
CN1163120A (en) | Medicine for curing tooth-ache and its preparation | |
CN1199632A (en) | Chinese medicine preparation as adjuvant for chemotherapy of tumour and its preparation process | |
CN1931242A (en) | Chinese medicine composition for treating cardio palmus and its prepn process | |
CN1362173A (en) | Nano medicine prepared with six mild drugs and Aucklandiae and Amomi and its preparation | |
CN1895405A (en) | Garden-Burnet-Sheng-Bai capsules and preparation thereof | |
CN1546147A (en) | Effervescence tablet for treating children's cough and asthma and its preparation | |
CN1106282A (en) | Medicament for treatment of cancer | |
CN1276770C (en) | Chinese medicinal composition for anticancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |